We then showed that Ang II, at concentrations mimicking the pathophysiological levels of the peptide in COVID-19 patients [29], potently enhanced ACE2 expression (Figure 1) by acting via AT1R (Figure 2). This evidence concerns the gene ACE2 and COVID-19.